Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/170559
Title: | Involvement of the 14-3-3 gene family in autism spectrum disorder and schizophrenia: Genetics, transcriptomics and functional analyses |
Author: | Torrico Avilés, Bàrbara Antón Galindo, Ester Fernàndez Castillo, Noèlia Rojo Francàs, Eva Ghorbani, Sadaf Pineda Cirera, Laura Hervás, Amaia Rueda, Isabel Moreno Guillén, Estefanía Fullerton, Janice M. Casadó, Vicent Buitelaar, Jan K. Rommelse, Nanda Franke, Barbara Reif, Andreas Chiocchetti, Andreas G. Freitag, Christine Kleppe, Rune Haavik, Jan Toma, Claudio Cormand Rifà, Bru |
Keywords: | Autisme Genètica humana Esquizofrènia Autism Human genetics Schizophrenia |
Issue Date: | 13-Jun-2020 |
Publisher: | MDPI |
Abstract: | The 14-3-3 protein family are molecular chaperones involved in several biological functions and neurological diseases. We previously pinpointed YWHAZ (encoding 14-3-3ζ) as a candidate gene for autism spectrum disorder (ASD) through a whole-exome sequencing study, which identified a frameshift variant within the gene (c.659-660insT, p.L220Ffs*18). Here, we explored the contribution of the seven human 14-3-3 family members in ASD and other psychiatric disorders by investigating the: (i) functional impact of the 14-3-3ζ mutation p.L220Ffs*18 by assessing solubility, target binding and dimerization; (ii) contribution of common risk variants in 14-3-3 genes to ASD and additional psychiatric disorders; (iii) burden of rare variants in ASD and schizophrenia; and iv) 14-3-3 gene expression using ASD and schizophrenia transcriptomic data. We found that the mutant 14-3-3ζ protein had decreased solubility and lost its ability to form heterodimers and bind to its target tyrosine hydroxylase. Gene-based analyses using publicly available datasets revealed that common variants in YWHAE contribute to schizophrenia (p = 6.6 × 10-7), whereas ultra-rare variants were found enriched in ASD across the 14-3-3 genes (p = 0.017) and in schizophrenia for YWHAZ (meta-p = 0.017). Furthermore, expression of 14-3-3 genes was altered in post-mortem brains of ASD and schizophrenia patients. Our study supports a role for the 14-3-3 family in ASD and schizophrenia. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/jcm9061851 |
It is part of: | Journal of Clinical Medicine, 2020, vol. 9, num. 6, p. 1851 |
URI: | http://hdl.handle.net/2445/170559 |
Related resource: | https://doi.org/10.3390/jcm9061851 |
ISSN: | 2077-0383 |
Appears in Collections: | Articles publicats en revistes (Genètica, Microbiologia i Estadística) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
699388.pdf | 869.34 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License